| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/18/2010 | CA2731108A1 Cmet inhibitors |
| 02/17/2010 | EP2154223A1 Thermal insulating foam comprising HFO-1233zd as blowing agent |
| 02/17/2010 | EP2154138A1 Novel compounds for treatment of psychotic disorders, preparation methods and uses thereof |
| 02/17/2010 | EP2154137A1 Crystalline form of moxifloxacin base |
| 02/17/2010 | EP2152710A2 4,4-disubstituted piperidine derivatives |
| 02/17/2010 | EP2152709A1 Morphinan compounds |
| 02/17/2010 | EP2152707A1 [6,5]-bicyclic gpr119 g protein-coupled receptor agonists |
| 02/17/2010 | EP2152706A1 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as p38 modulators, process for their preparation, and their pharmaceutical use |
| 02/17/2010 | EP2152705A1 9- (pyrazol- 3 -yl) - 9h- purine-2 -amine and 3- (pyraz0l-3-yl) -3h-imidaz0 [4, 5-b]pyridin-5-amine derivatives and their use for the treatment of cancer |
| 02/17/2010 | EP2152704A1 Pyrazolo-pyridinone compounds, process for their preparation, and their pharmaceutical use |
| 02/17/2010 | EP2152695A2 Gamma secretase modulators |
| 02/17/2010 | EP2152664A1 Dipeptide analogs as coagulation factor inhibitors |
| 02/17/2010 | EP2152660A2 Photocrosslinkable materials comprising alicyclic group |
| 02/17/2010 | EP1828200B1 Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer's disease. |
| 02/17/2010 | EP1347950B1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
| 02/17/2010 | CN101652364A New indole derivative compounds and pharmaceutical compositions containing the same |
| 02/17/2010 | CN100590124C Tricyclic androgen receptor modulator compounds and method |
| 02/16/2010 | US7662833 metalloproteinases inhibitor, particular Peptide Deformylase (Pdf) inhibitor; antibiotic; e.g. 2-(6-fluoro-imidazo[1,2-a]pyridin-3-ylamino)-N-hydroxy-acetamide |
| 02/16/2010 | US7662832 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof |
| 02/16/2010 | US7662831 N-5,6,9,10,11,12-hexahydro-4H,8H-cyclohepta[4,5]pyrrolo[3,2,1-ij]quinolin-2-yl-3,3-dimethylbutanamide; for treating cardiovascular disorders, nervous system disorders e.g epilepsy, episodic ataxia type 1, paroxysmal dyskinesia, neurodegenerative spincerebrallar ataxia, Parkinson's disease |
| 02/16/2010 | US7662828 Substituted 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-2-yl compounds and 5,6,7,8-tetrahydroquinazoline-2-yl compounds |
| 02/16/2010 | US7662827 Pyrazole derivatives having tyrosine kinase inhibitory activity |
| 02/16/2010 | US7662823 non-nucleoside reverse transcriptase inhibitors; for treatment of HIV and AIDS |
| 02/16/2010 | US7662822 Substituted azaquinazolines having an antiviral action |
| 02/16/2010 | US7662818 e.g. 4-[5-(piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; and multiple sclerosis |
| 02/16/2010 | US7662808 Diazabicyclic aryl derivatives as cholinergic receptor modulators |
| 02/16/2010 | CA2571627C Substituted aryl-amine derivatives and methods of use |
| 02/16/2010 | CA2478183C Substituted amides |
| 02/16/2010 | CA2450922C Piperidines for use as orexin receptor antagonists |
| 02/16/2010 | CA2406095C Synthetic process for the manufacture of an ecteinaschidin compound |
| 02/16/2010 | CA2385938C Cyclic amine compounds as ccr5 antagonists |
| 02/16/2010 | CA2308551C Phenanthroline derivatives |
| 02/11/2010 | WO2010017105A1 Urotensin ii receptor antagonists |
| 02/11/2010 | WO2010016846A1 Heterocyclic modulators of tgr5 for treatment of disease |
| 02/11/2010 | WO2010016549A1 Tricyclic compound |
| 02/11/2010 | WO2010016490A1 Imidazopyridin-2-on derivative |
| 02/11/2010 | WO2010016005A1 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors |
| 02/11/2010 | WO2010015985A1 Tricyclic alkylaminomethyloxazolidinone derivatives |
| 02/11/2010 | WO2010015803A1 Diazaindole derivatives and their use in the inhibition of c-jun n-terminal kinase |
| 02/11/2010 | WO2010015636A1 Beta-carbolin-derivates as substrates for an enzyme |
| 02/11/2010 | WO2010015589A1 Benzyl-substituted tetracyclic heterocyclic compounds as pde5 inhibitors |
| 02/11/2010 | WO2010015588A1 Benzyl-substituted tetracyclic heterocyclic compounds |
| 02/11/2010 | WO2010015587A1 5-benzyl-1,2,3,6-tetrahydro-4,6-diaza-cyclopenta[c]fluorene compounds and 5-benzyl-1,2,3,6-tetrahydro-4,6-diaza-cyclohepta[c]fluorene compounds |
| 02/11/2010 | WO2010015586A2 2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds |
| 02/11/2010 | WO2010015585A1 6-benzyl-2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds |
| 02/11/2010 | WO2010015524A1 Method for stereoselective synthesis of bicyclic heterocyclene |
| 02/11/2010 | WO2010015520A1 Substituted naphthyridines and use thereof as medicines |
| 02/11/2010 | WO2010015518A2 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments |
| 02/11/2010 | WO2010015090A1 Functionalized pyrrolidines and use thereof as iap inhibitors |
| 02/11/2010 | WO2009138386A3 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use |
| 02/11/2010 | US20100036129 Process for the preparation of imidazopyridines |
| 02/11/2010 | US20100036118 Fused Ring Heterocycle Kinase Modulators |
| 02/11/2010 | US20100036102 Novel chelating agents and highly luminescent and stable chelates and their use |
| 02/11/2010 | US20100035920 SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS AND THEIR METHODS OF USE |
| 02/11/2010 | US20100035919 Compounds useful as inhibitors of protein kinases |
| 02/11/2010 | US20100035918 Imidazolone Compounds and Methods of Making and Using the Same |
| 02/11/2010 | US20100035917 Pyrrolo[2,3-b]pyridin-4-yl-benzenesulfonamide compounds as 1kk2 inhibitors |
| 02/11/2010 | US20100035916 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy |
| 02/11/2010 | US20100035915 Indolizine derivatives and the use thereof as antidiabetics |
| 02/11/2010 | US20100035912 Small Molecule Inhibitors of Retroviral Assembly and Maturation |
| 02/11/2010 | US20100035902 5-aryl-substituted dihydropyridopyrimidines and dihydropyridazines and use thereof as mineral corticoid antagonists |
| 02/11/2010 | US20100035898 Organic compounds |
| 02/11/2010 | US20100035893 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/11/2010 | US20100035892 Method for assembling high-purity chemical libraries, compounds suppressing acetyl coenzyme a carboxylase activities discovered by same |
| 02/11/2010 | US20100035884 Kinase inhibitor |
| 02/11/2010 | US20100035883 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) |
| 02/11/2010 | US20100035878 Inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders relating to apoptosis and/or inflammation |
| 02/11/2010 | US20100035875 Triazolopyridine jak inhibitor compounds and methods |
| 02/11/2010 | US20100035869 Targeted nitroxide agents |
| 02/11/2010 | US20100035756 Triazolophyridine derivatives as herbicides |
| 02/11/2010 | US20100035279 Fluorescent Substrates for Monoamine Transporters as Optical False Neurotransmitters |
| 02/11/2010 | DE102008036495A1 New naphthalene, perylene, benzoperylene, terrylene, quaterrylene bisimide and trisimide anions, as salts, e.g. tetrabutylammonium- or potassium-salts, useful e.g. to prepare dyes, preferably vats dye, to color cotton, paper and nylon |
| 02/11/2010 | CA2732950A1 Imidazopyridin-2-one derivatives |
| 02/11/2010 | CA2732762A1 Urotensin ii receptor antagonists |
| 02/11/2010 | CA2732520A1 Therapeutic compounds |
| 02/11/2010 | CA2732087A1 Substituted naphthyridines and their use as medicaments |
| 02/11/2010 | CA2731926A1 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments |
| 02/11/2010 | CA2731895A1 Process for the stereoselective preparation of bicyclic heterocycles |
| 02/11/2010 | CA2731368A1 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors |
| 02/11/2010 | CA2731365A1 Tricyclic alkylaminomethyloxazolidinone derivatives |
| 02/10/2010 | EP2151441A1 Beta-carbolin-derivates as substrates for an enzyme |
| 02/10/2010 | EP2151435A1 Pharmaceutical composition for treatment of alzheimer's disease |
| 02/10/2010 | EP2150552A1 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression |
| 02/10/2010 | EP2150543A2 Heterocyclic compounds with affinity to muscarinic receptors |
| 02/10/2010 | EP2150255A1 Quinoxaline derivatives as p13 kinase inhibitors |
| 02/10/2010 | EP2086965B1 Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |
| 02/10/2010 | EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/10/2010 | EP1490365B1 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 02/10/2010 | CN101646668A Heterocycles as orexin antagonists |
| 02/10/2010 | CN101643475A Amide substituted imidazole[1,2-a] pyridine compounds, preparation method thereof and application thereof |
| 02/09/2010 | US7659398 Heating 4-chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline with ammonia in a polar aprotic solvent to produce imiquimod; purification; industrial scale; dechlorination; precipitation, crystallization, slurrying, washing in a suitable solvent, filtration through a packed-bed column, dissolution in solvent |
| 02/09/2010 | US7659298 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethylsulphanyl)-N-quinolin-3-ylbenzamide; 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethoxy)-N-naphthalin-2-ylbenzamide; obesity, including obesity of the non-insuline-dependent diabetes patients, sleeping disorders, stroke, nausea and vomiting |
| 02/09/2010 | US7659283 Pyrrolo [3,2-C] pyridines useful as inhibitors of protein kinases |
| 02/09/2010 | CA2557576C Novel benzothiazepine and benzothiepine compounds |
| 02/09/2010 | CA2451962C Ecl labels having improved non-specific binding properties, methods of using and kits containing the same |
| 02/09/2010 | CA2440760C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 02/09/2010 | CA2430690C Perylene pigment compositions |
| 02/09/2010 | CA2291065C Raf kinase inhibitors |
| 02/09/2010 | CA2274201C Di-or triaza-spiro[4,5]decane derivatives |
| 02/09/2010 | CA2201863C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors |